Variation in the Presence of Neuraminidase Genes among Streptococcus pneumoniae Isolates with Identical Sequence Types

ABSTRACT Streptococcus pneumoniae frequently colonizes the upper respiratory tract of young children and is an important cause of otitis media and invasive disease. Carriage is more common than disease, yet the genetic factors that predispose a given clone for disease are not known. The relationship between capsule type, genetic background, and virulence is complex, and important questions remain regarding how pneumococcal clones differ in their ability to cause disease. Pneumococcal neuraminidase cleaves sialic acid-containing substrates and is thought to be important for pneumococcal virulence. We describe the distribution of multilocus sequence types (ST), capsule type, and neuraminidase genes among 342 carriage, middle ear, blood, and cerebrospinal fluid (CSF) pneumococcal strains from young children. We found 149 STs among our S. pneumoniae isolates. nanA was present in all strains, while nanB and nanC were present in 96% and 51% of isolates, respectively. The distribution of nanC varied among the strain collections from different tissue sources (P = 0.03). The prevalence of nanC was 1.41 (95% confidence interval, 1.11, 1.79) times higher among CSF isolates than among carriage isolates. We identified isolates of the same ST that differed in the presence of nanB and nanC. These studies demonstrate that virulence determinants, other than capsule loci, vary among strains of identical ST. Our studies suggest that the presence of nanC may be important for tissue-specific virulence. Studies that both incorporate MLST and take into account additional virulence determinants will provide a greater understanding of the pneumococcal virulence potential.

[1]  R. Gertz,et al.  Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. , 2006, Journal of clinical microbiology.

[2]  Donna Spiegelman,et al.  Easy SAS calculations for risk or prevalence ratios and differences. , 2005, American journal of epidemiology.

[3]  C. Byington,et al.  Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  K. Fennie,et al.  Genomic Subtraction Followed by Dot Blot Screening of Streptococcus pneumoniae Clinical and Carriage Isolates Identifies Genetic Differences Associated with Strains That Cause Otitis Media , 2005, Infection and Immunity.

[5]  K. Auranen,et al.  Invasiveness of Serotypes and Clones of Streptococcus pneumoniae among Children in Finland , 2005, Infection and Immunity.

[6]  S. Clarke,et al.  Genetic Analysis of Diverse Disease-Causing Pneumococci Indicates High Levels of Diversity within Serotypes and Capsule Switching , 2004, Journal of Clinical Microbiology.

[7]  E. Tuomanen,et al.  Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. , 2004, The Journal of infectious diseases.

[8]  S. Peterson,et al.  Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway , 2004, Molecular microbiology.

[9]  G. Mccracken,et al.  Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Sander Greenland,et al.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. , 2004, American journal of epidemiology.

[11]  J. Claverys,et al.  The Ami-AliA/AliB Permease of Streptococcus pneumoniae Is Involved in Nasopharyngeal Colonization but Not in Invasive Disease , 2004, Infection and Immunity.

[12]  H. Verbrugh,et al.  Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children , 2004, The Lancet.

[13]  E. Wald,et al.  Pneumococcal vaccines: do they prevent infection and how? , 2004, Current opinion in infectious diseases.

[14]  A. Sandgren,et al.  Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. , 2004, The Journal of infectious diseases.

[15]  W. Hanage,et al.  eBURST: Inferring Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from Multilocus Sequence Typing Data , 2004, Journal of bacteriology.

[16]  K. Auranen,et al.  Ability of Pneumococcal Serotypes and Clones To Cause Acute Otitis Media: Implications for the Prevention of Otitis Media by Conjugate Vaccines , 2004, Infection and Immunity.

[17]  J. Gilsdorf,et al.  Diversity and sharing of Haemophilus influenzae strains colonizing healthy children attending day-care centers , 2004, The Pediatric infectious disease journal.

[18]  H. Tettelin,et al.  Comparative Genomics of Streptococcus pneumoniae: Intrastrain Diversity and Genome Plasticity , 2004 .

[19]  G. Pozzi,et al.  Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia , 2003, Molecular microbiology.

[20]  B. Spratt,et al.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. , 2003, The Journal of infectious diseases.

[21]  J. Weiser,et al.  Neuraminidase Expressed by Streptococcus pneumoniae Desialylates the Lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a Paradigm for Interbacterial Competition among Pathogens of the Human Respiratory Tract , 2002, Infection and Immunity.

[22]  A. Camilli,et al.  Large‐scale identification of serotype 4 Streptococcus pneumoniae virulence factors , 2002, Molecular microbiology.

[23]  M. Sebert,et al.  Microarray-Based Identification of htrA, a Streptococcus pneumoniae Gene That Is Regulated by the CiaRH Two-Component System and Contributes to Nasopharyngeal Colonization , 2002, Infection and Immunity.

[24]  P. Andrew,et al.  Upper and Lower Respiratory Tract Infection by Streptococcus pneumoniae Is Affected by Pneumolysin Deficiency and Differences in Capsule Type , 2002, Infection and Immunity.

[25]  W. P. Schneider,et al.  Differential Fluorescence Induction Analysis of Streptococcus pneumoniae Identifies Genes Involved in Pathogenesis , 2002, Infection and Immunity.

[26]  T. Demaria,et al.  Comparison of structural changes of cell surface carbohydrates in the eustachian tube epithelium of chinchillas infected with a Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. , 2001, Microbial pathogenesis.

[27]  D. Greenberg.  Considerations for hepatitis B as part of a combination vaccine , 2001, The Pediatric infectious disease journal.

[28]  J. Yother,et al.  Requirement for Capsule in Colonization byStreptococcus pneumoniae , 2001, Infection and Immunity.

[29]  A. Schuchat,et al.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. , 2001, JAMA.

[30]  R. Hakenbeck,et al.  Mosaic Genes and Mosaic Chromosomes: Intra- and Interspecies Genomic Variation of Streptococcus pneumoniae , 2001, Infection and Immunity.

[31]  S. Kaplan,et al.  Acute otitis media caused by Streptococcus pneumoniae in children’s hospitals between 1994 and 1997 , 2001, The Pediatric infectious disease journal.

[32]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[33]  S. Pelton.  Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge? , 2000, Vaccine.

[34]  B. Spratt,et al.  Prevention of pneumococcal disease by vaccination: does serotype replacement matter? , 2000, The Lancet.

[35]  S. Black,et al.  Efficacy of pneumococcal conjugate vaccines in large scale field trials , 2000, The Pediatric infectious disease journal.

[36]  J. M. Smith,et al.  Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data. , 2000, Genetics.

[37]  J. Claverys,et al.  Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination‐mediated genetic plasticity? , 2000, Molecular microbiology.

[38]  M. Lipsitch.  Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. , 1999, Emerging infectious diseases.

[39]  A. Tomasz,et al.  Acquisition of new capsular genes among clinical isolates of antibiotic-resistant Streptococcus pneumoniae. , 1999, Microbial drug resistance.

[40]  B. Spratt,et al.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. , 1998, Microbiology.

[41]  B. Spratt,et al.  Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae , 1998, Molecular microbiology.

[42]  D. Simon,et al.  Large-scale identification of virulence genes from Streptococcus pneumoniae. , 1998, Infection and immunity.

[43]  J. Paton,et al.  Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli , 1996, Journal of bacteriology.

[44]  P. Andrew,et al.  A neuraminidase from Streptococcus pneumoniae has the features of a surface protein , 1994, Infection and immunity.

[45]  J. P. Dillard,et al.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae , 1994, Infection and immunity.

[46]  R. Austrian.  The quellung reaction, a neglected microbiologic technique. , 1976, The Mount Sinai journal of medicine, New York.

[47]  G. Schiffman,et al.  SOME BIOLOGICAL PROPERTIES OF PNEUMOCOCCUS TYPE 37 AND THE CHEMISTRY OF ITS CAPSULAR POLYSACCHARIDE , 1970, The Journal of experimental medicine.